A. Kawamura

Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach.

Y. Nagai, Yasuyuki Abe, K. Shimada, 2015, Bioorganic & medicinal chemistry.

Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration.

K. Shimada, Kazuhiro Yoshida, Hisashi Takahashi, 2014, Bioorganic & medicinal chemistry letters.